Back

drs. X.Y.Y. Hagendoorn

drs. X.Y.Y. Hagendoorn

Full Professor

Show full profile

Research Output (114)

Mitotic count can predict tamoxifen benefit in postmenopausal breast cancer patients while Ki67 score cannot

Beelen Karin, Opdam Mark, Severson Tesa, Koornstra Rutger, Vincent Andrew, Wesseling Jelle, Sanders Joyce, Vermorken Jan, van Diest Paul, Linn Sabine 24 Jul 2018, In: BMC Cancer. 18

Optimal adjuvant endocrine treatment of ER+/HER2+ breast cancer patients by age at diagnosis:A population-based cohort study

Dackus G. M.H.E., Jóźwiak Katarzyna, Sonke Gabe S, van der Wall E., van Diest P. J., Hauptmann M., Siesling S., Linn S. C. 21 Dec 2017, In: European Journal of Cancer. 90 , p. 92-101 10 p.

BRCA1-like profile is not significantly associated with survival benefit of non-myeloablative intensified chemotherapy in the GAIN randomized controlled trial

van Rossum A. G.J., Schouten Philip C, Weber K. E., Nekljudova V., Denkert Carsten, Solbach C., Köhne C. H., Thomssen C., Forstbauer H., Hoffmann G., Kohls A., Schmatloch S., Schem C., von Minckwitz G., Karn T., Möbus V. J., Linn S. C., Loibl S., Frederik Marmé Marmé Dec 2017, In: Breast Cancer Research and Treatment. 166 , p. 775-785 11 p.

Long-term prognosis of young breast cancer patients (≤40 years) who did not receive adjuvant systemic treatment:protocol for the PARADIGM initiative cohort study

Dackus Gwen Mhe, Ter Hoeve Natalie D., Opdam Mark, Vreuls Willem, Varga Zsuzsanna, Koop Esther, Willems Stefan M., Van Deurzen Carolien Hm, Groen Emilie J., Cordoba Alicia, Bart Jos, Mooyaart Antien L., van den Tweel Jan G., Zolota Vicky, Wesseling Jelle, Sapino Anna, Chmielik Ewa, Ryska Ales, Amant Frederic, Broeks Annegien, Kerkhoven Ron, Stathonikos Nikolas, Veta Mitko, Voogd Adri, Jozwiak Katarzyna, Hauptmann Michael, Hoogstraat Marlous, Schmidt Marjanka K., Sonke Gabe, van der Wall Elsken, Siesling Sabine, van Diest Paul J., Linn Sabine C. 14 Nov 2017, In: BMJ open [E]. 7

Extended adjuvant aromatase inhibition after sequential endocrine therapy (DATA):a randomised, phase 3 trial

Tjan-Heijnen Vivianne C G, van Hellemond Irene E G, Peer Petronella G M, Swinkels Astrid C P, Smorenburg Carolien H, van der Sangen Maurice J C, Kroep Judith R, De Graaf Hiltje, Honkoop Aafke H, Erdkamp Frans L G, van den Berkmortel Franchette W P J, de Boer Maaike, de Roos Wilfred K, Linn Sabine C, Imholz Alexander L T, Seynaeve Caroline M, Nov 2017, In: LANCET ONCOLOGY. 18 , p. 1502-1511 10 p.

Stimulation of the ovaries in women with breast cancer undergoing fertility preservation:Alternative versus standard stimulation protocols; the study protocol of the STIM-trial

Dahhan T., Balkenende E.M., Beerendonk C. C.M., Fleischer K., Stoop D., Bos A. M.E., Lambalk Cornelis B., Schats R, van Golde Ron J T, Schipper I., Louwé L. A., Cantineau A. E.P., Smeenk Jesper M J, Bruin Jacob P, Reddy D N, Kopeika Y., van der Veen F, Wely M., Linn S. C., Goddijn M. 1 Oct 2017, In: Contemporary Clinical Trials. 61 , p. 96-100 5 p.

The BRCA1ness signature is associated significantly with response to PARP inhibitor treatment versus control in the I-SPY 2 randomized neoadjuvant setting

Severson Tesa M, Wolf Denise M., Yau Christina, Peeters Justine K, Wehkam Diederik, Schouten Philip C, Chin Suet-Feung, Majewski Ian J, Michaut Magali, Bosma Astrid J, Pereira Bernard, Bismeijer Tycho, Wessels Lodewyk F A, Caldas Carlos, Bernards René, Simon Iris M, Glas Annuska M., Linn Sabine, Van't Veer Laura J. 25 Aug 2017, In: Breast Cancer Research. 19

Impact of 70-gene signature use on adjuvant chemotherapy decisions in patients with estrogen receptor–positive early breast cancer:Results of a prospective cohort study

Kuijer Anne, Straver Marieke, den Dekker Bianca, Van Bommel Annelotte C.M., Elias Sjoerd G., Smorenburg Carolien H., Wesseling Jelle, Linn Sabine C., Rutgers Emiel J. Th., Siesling Sabine, Dalen Thijs van 20 Aug 2017, In: Journal of Clinical Oncology. 35 , p. 2814-2819 6 p.

Neoadjuvant Therapy for Breast Cancer:Established Concepts and Emerging Strategies

Steenbruggen Tessa G, van Ramshorst Mette S., Kok Marleen, Linn Sabine C., Smorenburg Carolien H., Sonke Gabe S 1 Aug 2017, In: Drugs. 77 , p. 1313-1336 24 p.

Therapeutic rationale to target highly expressed CDK7 conferring poor outcomes in triple-negative breast cancer

Li Bo, Chonghaile Triona Ni, Fan Yue, Madden Stephen F., Klinger Rut, O'Connor Aisling E., Walsh Louise, O'Hurley Gillian, Udupi Girish Mallya, Joseph Jesuchristopher, Tarrant Finbarr, Conroy Emer, Gaber Alexander, Chin Suet-Feung, Bardwell Helen A, Provenzano Elena, Crown John, Dubois Thierry, Linn Sabine, Jirstrom Karin, Caldas Carlos, O'Connor Darran P, Gallagher William M 15 Jul 2017, In: Cancer Research. 77 , p. 3834-3845 12 p.

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht

Contact

Emergency?

Directions

Appointments

Practical

umcutrecht.nl uses cookies

This website uses cookies This website displays videos from, among others, YouTube. Such parties place cookies (third-party cookies). If you do not want these cookies, you can indicate that here. We also place cookies ourselves to improve our site.

Read more about the cookie policy

Agree No, rather not